STUDI PENGGUNAAN PENCAHAR PADA PASIEN KANKER YANG MENGGUNAKAN ANALGESIK OPIOID (Penelitian dilakukan di Poli Paliatif dan Bebas Nyeri RSUD Dr. Soetomo Surabaya) by TRI JULIYANTO, 051411131133
IR-PERPUSTAKAAN UNIVERSITAS AIRLANGGA 
 
xi 
SKRIPSI  STUDI PENGGUNAAN PENCAHAR…     TRI JULIYANTO 
ABSTRACT 
THE STUDY OF LAXATIVE UTILIZATION PATTERN IN 
CANCER PATIENTS USING OPIOID ANALGESICS  
(Conducted at Palliative and Pain Management Department of RSUD 
Dr. Soetomo Surabaya) 
Tri Juliyanto 
Constipation is a condition in which a person has decreased frequency 
of bowel movements (less than 3 times a week), resulting in dry, hard and 
small stool. One may experience pain when defecating. In some cases, 
bloating or pain in the ridge and chest area adds to the symptoms. 
Constipation is caused by lack of dietary fiber and physical activity, lifestyle 
changes, delaying the desire to defecate and use of certain drugs such as 
opioids. Approximately 40% to 95% of patients treated with opioid 
analgesics experience constipation as a side effect. 
This study’s purpose was to examine the utilization pattern of 
laxatives in overcoming constipation due to opioid analgesics in cancer 
patients of Palliative and Pain Management Department in RSUD Dr. 
Soetomo Surabaya, regarding to the class, duration and dose of laxative use. 
It also aimed to address Drug Related Problems (DRPs) related to the use of 
laxatives including indication appropriateness, dose conformity and side 
effects of laxatives. 
A retrospective, non-experimental (observational) study with 
descriptive analysis was conducted. The study samples were all new 
outpatients diagnosed with cancer in Palliative and Pain Management 
Department. All cancer patients using opioid analgesics that caused 
constipation and getting laxative therapy during the period of July 1st to 
December 31st, 2017 were included in the study. 
The results were as follows: There were 168 patients in total with 
laxative prescription and 420 patient visits issuing constipation. Prescribed 
laxatives were lactulose syrup, Bisacodyl oral tablets, Bisacodyl 
suppositories, fleet enema®, Laxadine®, and Microlax®. Some doses and 
prescribing frequency of Laxadine® were incompatible with literature, yet 
the dosage and prescribing frequency of the others were in accordance with 
the literature. DRP recorded in the study were diarrhea after laxative 
treatment in 3 cases. 
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